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The aim of this research was to determine the effect of soy germ protein on lipid profile of metabolic
syndrome (MetS) patients. Respondents were 30 women with criteria, i.e. blood glucose level > normal, body
mass index > 25 kg/m2, hypertriglyceridemia, low cholesterol-HDL level, 40-65 years old, living in Purwokerto,
and signed the informed consent. The project was approved by the ethics committee of the Medical Faculty from
Gadjah Mada University-Yogyakarta. Respondents were divided into three randomly chosen groups consisting of
ten women each. The first, second, and third groups were treated, respectively, with milk enriched soy germ
protein plus Zn, milk enriched soy germ protein (without Zn), and placebo for two months. Blood samples were
taken at baseline, one and two months after observation. Two months after observation the groups consuming
milk enriched with soy germ protein, both with or without Zn, had their level of cholesterol-total decrease from
215.8 to 180.2 mg/dl  (P = 0.03), triglyceride from 240.2 to 162.5 mg/dl (P = 0.02), and LDL from 154.01
to 93.85 mg/dl (P = 0.03). In contrast, HDL increased from 38.91 to 49.49 mg/dl (P = 0.0008). In conclusion, soy
germ protein can improve lipid profile, thus it can inhibit atherosclerosis incident.
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INTRODUCTION
Metabolic syndrome (MetS) is a group of disease
symptoms that arise as the effects of metabolic disorders.
Hill et al. (2003) reported that MetS patients were
dominated by women. MetS is charracterized by obesity
that is mainly accompanied with two or more of the
following four risk factors, i.e. type-2 diabetes mellitus
(T-2DM), hypertriglyceridemic, low level HDL-cholesterol,
and high blood pressure. While obesity is known to be
one of the trigger factors for hypercholesterolemic,
hypertriglyceridemic, low level HDL-Cholesterol, and high
LDL-Cholesterol level, it is believed that in obesity
condition, the adipose tissue and macrophage are
infiltrated by inflammatory cytokine, and, as a result, fat is
accumulated in the adipose while cholesterol is
accumulated in the macrophage. The obesity condition
causes excessive endoplasmic reticulum damage due to
oxidative stress (Furukawa et al. 2004). This is due to the
structural changes and the increase of fat and cholesterol
synthesis of the adipose.
High level of LDL-Cholesterol might disturb the
metabolism and, if it is not recovered immediately, this
lipoprotein compound will stay on the wall of blood vein
and might generate cholesterol plaque. Sooner or later,
the plaque will become thicker, tear the arterial wall layer,
and, finally, thrombus will be produce which will cause a
disturbance in the arterial blood stream. Continuous
thrombus formation will totally plug the coronary blood
vein and, in turn, stop the oxygen stream into the heart
muscle. This can result in infarction myocardial and
eventually a heart attack (Arsana et al. 2007). In addition,
the high level of HDL-Cholesterol has the possibility to
infiltrate the intima tunica, oxidize the first level and form
LDL-oxidized (LDL-ox). The LDL-ox that is formed induces
the formation of adhesive compounds and patches that
attract the monocytes to penetrate the endhotelial layer
into the tunica intima. Consequently, the high level of
LDL-Cholesterol leads to the constriction and the clog of
the blood stream, also called atherosclerosis. Finally, the
heart will havedifficulty in pumping blood which is
followed by the appearance of sudden heart attack
symptoms.
The function of HDL-Cholesterol is to extract excess
cholesterol deposites in the vein walls and return it to the
liver which will eliminate it through the digestive tract
(Staels & Fonseca 2009). Consequently, a high cholesterol-
HDL level is very useful in lowering the atherosclerosis
risk. Asztalos et al. (2000) said that for every increase
of 1 unit of cholesterol-HDL the risk of coronary heart
disease decreases by 2-3%. Therefore, the HDL level needs
to be increased.
Copyright © 2012 Institut Pertanian Bogor. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
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Researchers reported that soy protein is able to
improve the lipid profile (Anderson et al. 1995; Winarsi
2007). It was also reported that soy germs contain higher
protein levels than soy seeds (Winarsi et al. 2010).
However, data about the potential of soy germ protein in
improving the profile of metabolic syndrome in women is
not available yet.
The aim of thise research was to explore the potential
of soy germ protein in decreasing total cholesterol,
triglycerides, LDL, and increasing HDL on metabolic
syndrome in women patients.
MATERIALS  AND  METHODS
This research involved 30 metabolic syndrome women
fitting the following criterias: BMI > 25 kg/m2, high blood
glucose level in time (> normal), high blood pressure,
elevated triglycerides, low levels of high density
lipoprotein, age range of 40-65 years, living in Purwokerto,
and willing to sign the informed consent. The research
was approved by the ethics committee from the Medical
Faculty of Gadjah Mada University-Yogyakarta. They were
divided into 3 groups of 10 women (Table 1). Group I was
treated with milk enriched soy germ protein plus Zn, group
II was treated with milk enriched soy germ protein (without
Zn), and group III was the placebo (Table 2) for the period
of two months with 25 g/d. Throughout the research,
recalls of food consumption was performed for 8 times.
Their blood samples were taken 3 times, i.e. baseline, and
continued with 1 and 2 months after observation. Two ml
of blood was collected in venoject-tubes containing
EDTA, intravenously, and finally the total cholesterol level,
triglycerides, HDL, and LDL was determined.
Determination of the Total Cholesterol Level (CHOD-
PAP Method). Blood sample was centrifuged at 2000 rpm
for 20 minutes to obtain the plasma. As much as 1000 μl of
reagent was used as the blank. Plasma of 10 μl was added
in 1000 μl of cholesterol reagent Dyasis®, and then
incubated for 10 minutes. The sample was read after the
blank was read using photometer 5010 in 546 nm
wavelength.
Determination of the Triglycerides Level (glycerol-
3-phosphateoxidase (GPO) method). An amount of 10 μl
blood sample was added to 1000 μl of reagent. 1000 μl of
reagent was used as the blank. Each solution was
homogenized and incubated for 20 minutes at 20-25 oC, or
10 minutes at 37 oC. The absorption of each sample was
read in 500 nm wavelength. Triglycerides level was then
calculated with the following formula:
C = Triglycerides level,  A =  Absorbances, Cst =
Triglycerides standard level  (200 mg/dl).
Determination of the Cholesterol-HDL Level
(Burstein Method). 0.1 ml of plasma was added to a reaction
tube  containing 0.25 ml of cholesterol-HDL reagent, and
homogenized. A sample of the solution was incubated for
10 minutes at room temperature, and centrifuged in 2000 rpm
for 10 minutes. 100 μl of the supernatant was reacted with
1000 μl of reagent. The sample was read in 546 nm
wavelength.
Determination of the LDL-Cholesterol Level
(Freidewald Method) (Astawan et al. 2005). Cholesterol-
LDL level measurement was carried out by using the
following formula:
Cholesterol-LDL level = Total cholesterol –
(Triglyceride / 5)  –  cholesterol-HDL
Statistical Analysis. The data obtained was presented
as an average + standard error. All of the data was
analyzed by using an analysis of variance (Anova).
Pearson’s correlation coefficient was used to determine
the correlation between variables, if there was significantly
difference (P < 0.05).
C =
Asample X  CstAstandard
Table1. Profile of metabolic syndrome women
Profile                                                                A                                        B                                       C                                  P=
Age (Year)
BMI (kg/m2)
Blood glucose level (mg/dl)
Triglyceride level (mg/dl)
HDL level (mg/dl)
Blood pressure
Sistole (mmHg)
Diastole (mmHg)
50.2 + 2.0
31.0 + 1.1
221.2 + 15.36
236.4 + 37.9
45.19 + 3
156 + 9
106 + 2
51.5 + 2.3
31.2 + 0.7
213.7 + 6.8
204 + 22.8
48.73 + 2
149 + 8
108 + 7
49.5 + 2.3
33.3 + 0.9
223.3 + 8.83
212 + 30.4
45.87 + 2.3
154 + 6
102 + 4
0.81
0.21
0.81
0.74
0.61
0.81
0.71
A: milk enriched soy germ protein plus Zn, B: milk enriched soy germ protein without Zn, C: placebo, n: 10, data presented in average
+ SEM.
Table 2. The chemistry composition of milk rich soy germ protein*
Component                             Milk enriched soy germ protein + Zn               Milk enriched soy germ protein                 Placebo
Water (%)
Ash (%)
Fat (%)
Protein (%)
Carb (%) by difference
Total (%)
4.79 + 0.08
22.68 + 0.07
1.11 + 0.01
42 + 0.05
29.39 + 0.04
100 + 0.005
4.6 + 0.008
22.6 + 0.09
1.02 + 0.003
39.5 + 0.09
32.27 + 0.02
100 + 0.03
4.5 + 0.003
22.4 + 0.006
1.04 + 0.003
36.7 + 0.037
35.03 + 0.32
100 + 0.03
*data presented in 3 repeated, average + SEM, Winarsi and Purwanto (2010).
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RESULTS
The baseline time of each treatment group showed no
difference in data, i.e. ages (P = 0.55), BMI (P = 0.1), level
of triglycerides (P = 0.83), HDL (P = 0.4), and blood
pressure (P = 0.64). It means that at the initial time, the
subjects’ conditions were homogenous. It could be
concluded that the change that exist after observation
was the effect of giving the supplement to the subjects.
The Total Cholesterol Level. In baseline time, the total
cholesterol level was 216.7 + 68 mg/dl, but it did not show
the difference among treatment groups (P = 0.69). One
month after observation, their cholesterol level did not
change (P = 0.9), but two months later the level had
decreased from 215.8 to180.2 mg/dl (P = 0.03). In fact, in
the group consuming milk enriched with soy germ protein
without Zn, the level had also significantly decreased from
215.8 to 182.6 mg/dl (P = 0.04). Therefore, the cholesterol
level in a group consuming milk enriched with soy germ
protein plus Zn was not different from the group
consuming it without Zn (P = 0.89) (Figure 1).
The Triglyceride Level. At baseline time the average
level of triglyceride was 208.05 + 26.64 mg/dl, and the levels
were not different among treatment groups (P = 0.74).
Triglyceride is the lipid found in blood circulation, so it is
also called lipid. One month after observation, the level
of triglyceride did not change (P = 0.73), but two months
later, their level had decreased from 240.2 to 162.5 mg/dl (P =
0.02) in the group consuming milk enriched with soy germ
protein plus Zn, while in the group consuming milk
enriched with soy germ protein without Zn, the level
decreased from 244.7 to 176.2 mg/dl (P = 0.03) (Figure 2).
Both of the groups did not have different triglyceride levels
(P = 0.35).
The HDL Level. Initially, the HDL levels of MetS
patients was 47.3 + 2.4 mg/dl, and was not different among
the treatment groups (P = 0.61). This was also true for one
month after observation. However, two months after
observation started, the level increased from 38.91 to
49.49 mg/dl (P = 0.0008) in the group consuming milk
enriched with soy germ protein plus Zn, while in the group
consuming it but without Zn, the level increased from
38.91 to 43.41 mg/dl (P = 0.03) (Figure 3). Thus, the Zn
enrichment did not influence the HDL level.
The LDL-Cholesterol Level. The average LDL-
Cholesterol level in the baseline time was 159.6 + 8.06 mg/dl,
and was not different among the treatment groups (P = 0.64).
One month later, the LDL level did not change (P = 0.74).
However, two month after, the level decreased from 154.01
to 93.85 mg/dl (P = 0.03) in the group consuming milk
enriched with soy germ protein plus Zn, while, in the group
consuming milk enriched with soy germ protein without
Zn, the level decreased from 154.01 to 115.44 mg/dl
(P = 0.04). Both of the groups did not show any difference
in terms of LDL-Cholesterol level (P = 0.64) (Figure 4).
In this study, a recall of food consumption was also
conducted. However, the results yield no difference
between the groups for both dietary protein intake (P = 0.14)
and the calories (P = 0.17). Thus, their food intake had no
effect on their lipid profile.
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Figure 2. Triglyceride level in metabolic syndrome women. :
milk enriched soy germ protein +Zn, : milk enriched
soy germ protein, : placebo.
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Figure 1. Total cholesterol level in metabolic syndrome women. :
milk enriched soy germ protein +Zn, : milk enriched
soy germ protein, : placebo.
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Figure 3. HDL level in metabolic syndrome women. : milk
enriched soy germ protein +Zn, : milk enriched soy
germ protein, : placebo.
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DISCUSSION
Facts stated that in subjects that were identified as
hypercholesterolemia and obese, with a BMI level of
32.28 kg/m2, there was a big risk of diabetes. The results
showed that their blood glucose level in baseline time
was more than the normal level allowed. Consequently,
these subjects experienced diabetes, particularly type-2
diabetes mellitus (T2-DM). They were characterized as
insulin resistant conditions. Even-though the insulin level
was not analyzed, in insulant resistant conditions, the
hormones do not have the ability to push the glucose
into cells to perform metabolism, and the glucose produced
is accumulated in blood. The excess of glucose in the
blood is changed into glycerol-3-phosphate and fatty
acids at the same time, and used to synthesis triglyceride.
Triglyceride, then, transports hepatic very low density
lipoprotein (VLDL) into extra hepatics tissues, is lysed by
lipoprotein lipase to become the intermediate density
lipoproteins (IDL) (high triglycerides and protein is lost),
and is changed to LDL. Therefore, the increase of
cholesterol tissue is shown in the blood level.
This finding supported a research by Potter et al. (1998)
in which consuming 50 g/d soy protein had resulted in a
decrease of total cholesterol level for subjects with
hypercholesterolemia. The same result was also reported
in hypercholesterolemia rabbits or monkey (Anthony et
al. 1996; Anthony et al. 1998). Soy protein has been known
to suppress cholesterol and bile acids absorption in the
small intestine. However, they also induced the excretion
of bile acids and fecal steroids giving theliver more
opportunity to change the cholesterol in the body into
bile salt, This phenomenon affected the decrease of total
cholesterol in the body. Winarsi et al. (2010) reported that
protein content in soy germ was higher than that of in soy
non germ. Consequently, the soy germ protein’s ability to
decrease the total cholesterol in the body was higher
(15.27%) than soy non germ protein (11-12%).
Kanetro et al. (2008) added that soy germ protein,
which is enriched with amino acids such as arginine and
leusin, have potential in inducing insulin secretion.
Winarsi and Purwanto (2010) also said that insulin level
of type T-2DM was significantly increased after consuming
soy germ protein, with or without Zn, for two months. As
a result, the decrease of cholesterol level was correlated
with the increase of insulin level, whose activity was also
assumed to increase. The glucose was not accumulated
in blood, but it was pushed into cells and transformed
into energy in the metabolic process. The same condition
was also found in lipid synthesis where glucose was not
changed into fat, including cholesterol, which resulted in
an inhibition of triglyceride breaking. It can be concluded
that soy germ protein, with or without Zn, could decrease
the cholesterol level. In other words, Zn did not affect the
cholesterol level of metabolic syndrome patients.
Triglyceride. Fat from diet and the body are made
from triglycerides. A high level of triglyceride is often
correlated with the occurrence of heart disease.
Consequently, subjects with metabolic syndrome are
considered a risk for high triglycerides levels. Higher levels
of triglycerides might cause excess body weight or obesity
because cholesterol in the blood originates from the fat in
a diet or synthesized from other macro nutrients, like
carbohydrate. Unused calories from a diet is directly
changed into triglycerides, and saved in adipose tissues.
Krajcovicova-Kudlackova et al. (2005) claimed that
soy protein contains higher amounts of leusin than other
chained branch amino acids. Leusin is a substrate of
protein synthesis that has a role in maintaining glucose
and insulin homeostasis. Body weight is regulated by the
potential change in body composition, including non-fat
mass, and the stabilization of blood fasting or postprandial
glucose levels. Besides the eight essential amino acids,
soy protein also contains non-essential amino acids in
higher levels than that of chicken eggs. These amino acids
induce the release of glucagon hormone, which is
responsible for breaking enzymes that save fat, increasing
fat metabolism (fat burning), and decreasing cholesterol
synthesis. The amount of non-essential amino acids in
soy germ protein is assumed higher than that of soy
protein since the amount of protein in soy germ is higher
than that of soy. Thus, the potential of suppressing
cholesterol is also high.
Cholesterol is a result of triglyceride breaking. Thus, a
decrease in cholesterol level also suppresses the level of
triglyceride. This finding has been reported in many
previous researches, and it is believed that the decrease
of triglyceride plasma level correlates with anti-
atherogenicity of the HDL, particularly in the case of
cholesterol transport.
Increasing HDL levels with milk enriched with soy germ
protein supplements improves the regulation of lipid
metabolish which may be correlated with the potential of
the isoflavone binding protein found in the milk. Song et
al. (2003) said that soy isoflavone showed its capability
when it is mixed with protein. This finding supported the
opinion of Yousef et al. (2004) who mentioned that white
guinea pigs treated with 5 mg/kg body weight of soy
isoflavones for 13 weeks had increased HDL level as much
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Figure 4. LDL level in metabolic syndrome women. : milk enriched
soy germ protein +Zn, : milk enriched soy germ protein,
: placebo.
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as 39%. This was the same with results from a study by
Anderson et al. (1995) whose clinically tested subjects
had a 2% increase in HDL levels when treated with soy
protein.
Isoflavones, found in milk enriched with soy germ
protein, has an estrogen-like characteristic. This
phytoestrogen reduces lipase hepatic activity, but induces
apolipoprotein A-1 (protein compound in lipoprotein)
production. Apolipoprotein A-1 is a protein active with
lecithin cholesterol acyltransferase (LCAT), an enzyme
that changes free cholesterol to ester cholesterol (Miller
2003). Consequently, a higher level of esterified
cholesterol will progressively increase HDL levels.
Similar opinion could be found in Supriyanto (2004),
in which estrogen-like soy isoflavones induced
apolipoprotein A-1 production, and contributed in
increasing HDL levels. Initially, HDL was released as a
HDL nascent containing apolipoprotein (apo) A, C, and
E. Next, the  HDL nascent blocked the macrophage and let
cholesterols save them. Finally, the HDL nascent changed
into adult HDL. That finding was also supported by the
macrophage level, although it was not significant,
recording a monocyte decrease from 1.25 103  to 1.01 103/ul
(P = 0.04). The number of monocytes was greater than the
normal range, thus the decrease was needed. The
cholesterol saving the macrophage was also fewer, which
meant more HDL was formed. HDL-cholesterol is good
cholesterol. It cleans the blood vessels from the excess of
LDL-cholesterol. Higher HDL-cholesterol level supports
LDL-cholesterol level lower than 150 mg/dl, which is a
good marker to inhibit atherosclerosis.
In high level of LDL, corked and clothed vessels are
found in blood deposits. Lower LDL levels achieved using
soy germ protein supplements might be correllated with
the antioxidative potential of soy isoflavones. Soy and its
products function as the source of isoflavone. Winarsi et
al. (2010) suggested that soy germ protein isolate
contained larger amounts of isoflavones than ordinary
soy protein isolate.
Jenkins et al. (2002) added that consumption of soy
isoflavones (168 mg/d) could decrease the risk of
cardiovascular occurance through degradation of the LDL-
OX. This was also supported by a statement from Yousef
et al. (2004) that stated that white guinea pigs which were
treated with 5 mg/kg body weight of soy isoflavones for
13 weeks had a 22% decrease in LDL-cholesterol levels.
Zhan and Ho (2005) conducted 23 clinical tests from 1995
until 2002 and concluded that isoflavones of soy protein
decreased LDL levels by up to 5.25%. Consequently, the
decreasing LDL level of metabolic syndrome patients may
prove the antioxidative potential of isoflavones in soy
germ protein. Lower levels of LDL may cause a decrease
in VLDL hepatic secretion. VLDL, which has a high risk
oxidation and is very atherogenic, can suppress
triglycerides levels (fewer triglyceride was hydrolized by
lipase hepatic enzyme, resulting in a much lower VLDL
level) and prevent the formation of LDL-OX. Decreasing
LDL level by soy germ protein enriched with isoflavones
may inhibit atherosclerosis development.
It can be concluded that milk enriched soy germ
protein, with or without Zn, improved the lipid profile of
women with metabolic syndrome. It is suggested that
consuming soy germ protein regularly might prevent the
development of metabolic syndrome.
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